<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241008141410&amp;utm_medium=rss&amp;utm_source=Chrome&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;v=2.18.0.post9+e462414&amp;utm_campaign=pubmed-2
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241008141410&amp;utm_medium=rss&amp;utm_source=Chrome&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;v=2.18.0.post9+e462414&amp;utm_campaign=pubmed-2" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Tue, 08 Oct 2024 18:14:11 +0000</lastbuilddate>
<pubDate>Tue, 08 Oct 2024 06:00:00 -0400</pubDate>
<ttl>120</ttl>
<item>
<title>Highlights From the &lt;em>;Circulation&lt;/em>; Family of Journals</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39378021/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241008141410&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Sep 17;150(12):966-970. doi: 10.1161/CIRCULATIONAHA.124.071870. Epub 2024 Sep 16.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39378021/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241008141410&v=2.18.0.post9+e462414">39378021</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.071870>10.1161/CIRCULATIONAHA.124.071870</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39378021</guid>
<pubDate>Tue, 08 Oct 2024 06:00:00 -0400</pubDate>
<dc:date>2024-10-08</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Highlights From the &lt;em>;Circulation&lt;/em>; Family of Journals</dc:title>
<dc:identifier>pmid:39378021</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.071870</dc:identifier>
</item>
<item>
<title>Within-person stability of lipoprotein(a) concentration</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39375838/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241008141410&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Oct 8:ehae652. doi: 10.1093/eurheartj/ehae652. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39375838/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241008141410&v=2.18.0.post9+e462414">39375838</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae652>10.1093/eurheartj/ehae652</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39375838</guid>
<pubDate>Tue, 08 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Jonas Ghouse</dc:creator>
<dc:creator>Gustav Ahlberg</dc:creator>
<dc:creator>Søren Albertsen Rand</dc:creator>
<dc:creator>Morten Salling Olesen</dc:creator>
<dc:creator>Bjarni Vilhjalmsson</dc:creator>
<dc:creator>Stefan Stender</dc:creator>
<dc:creator>Henning Bundgaard</dc:creator>
<dc:date>2024-10-08</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Within-person stability of lipoprotein(a) concentration</dc:title>
<dc:identifier>pmid:39375838</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae652</dc:identifier>
</item>
<item>
<title>Focus on the European Society of Cardiology: Guidelines on hypertension, Atlas of cardiovascular disease statistics, and Consensus statement on obesity</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39374627/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241008141410&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Oct 7;45(38):3897-3900. doi: 10.1093/eurheartj/ehae664.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39374627/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241008141410&v=2.18.0.post9+e462414">39374627</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae664>10.1093/eurheartj/ehae664</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39374627</guid>
<pubDate>Mon, 07 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Filippo Crea</dc:creator>
<dc:date>2024-10-07</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Focus on the European Society of Cardiology: Guidelines on hypertension, Atlas of cardiovascular disease statistics, and Consensus statement on obesity</dc:title>
<dc:identifier>pmid:39374627</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae664</dc:identifier>
</item>
<item>
<title>Carbon dioxide for neurogenic orthostatic hypotension in adults: a novel therapy</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39374345/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241008141410&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Oct 7:ehae653. doi: 10.1093/eurheartj/ehae653. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39374345/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241008141410&v=2.18.0.post9+e462414">39374345</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae653>10.1093/eurheartj/ehae653</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39374345</guid>
<pubDate>Mon, 07 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Jacquie R Baker</dc:creator>
<dc:creator>Shaun I Ranada</dc:creator>
<dc:creator>Anthony V Incognito</dc:creator>
<dc:creator>Robert S Sheldon</dc:creator>
<dc:creator>Carlos A Morillo</dc:creator>
<dc:creator>Richard J A Wilson</dc:creator>
<dc:creator>Aaron A Phillips</dc:creator>
<dc:creator>Satish R Raj</dc:creator>
<dc:date>2024-10-07</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Carbon dioxide for neurogenic orthostatic hypotension in adults: a novel therapy</dc:title>
<dc:identifier>pmid:39374345</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae653</dc:identifier>
</item>
<item>
<title>Is myocardial accumulation of non-transferrin-bound iron clinically relevant?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39374343/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241008141410&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Oct 7:ehae560. doi: 10.1093/eurheartj/ehae560. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39374343/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241008141410&v=2.18.0.post9+e462414">39374343</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae560>10.1093/eurheartj/ehae560</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39374343</guid>
<pubDate>Mon, 07 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Stephan von Haehling</dc:creator>
<dc:creator>Ryosuke Sato</dc:creator>
<dc:creator>Stefan D Anker</dc:creator>
<dc:date>2024-10-07</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Is myocardial accumulation of non-transferrin-bound iron clinically relevant?</dc:title>
<dc:identifier>pmid:39374343</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae560</dc:identifier>
</item>
<item>
<title>Abdominal aortic aneurysm repair in Sweden vs. Finland: benefits of population-wide screening</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39374339/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241008141410&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: This study reveals improvements in results of AAA repair in Sweden. A decrease in rAAA repair and increase in iAAA repair were evident after AAA screening was started in 2006 and resulted in better outcomes. These changes are likely the result of AAA screening as they cannot be seen in neighbouring Finland that is lacking an AAA screening programme.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Oct 7:ehae665. doi: 10.1093/eurheartj/ehae665. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: In 2006, screening of 65-year-old men for abdominal aortic aneurysm (AAA) was started in Sweden. Decline in aneurysm-related mortality has been reported since, but aneurysm incidence has been diminishing globally. Neighbouring Finland with similar population structure and health care system has no AAA screening programme. The aim of this study was to compare incidence and results of AAA repair in Sweden and Finland to differentiate the effect of screening from other changes in the epidemiology and treatment of AAA.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: All repairs for intact AAA (iAAA) or ruptured AAA (rAAA) from 1998 to 2017 were identified from national registers, and mortality data for these patients were collected.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: A total of 15 927 operations for iAAA were performed in Sweden and 6933 in Finland. In Sweden, the yearly operation volume increased after introduction of screening. Both countries showed a decrease in number of rAAA operations, but the decrease was more pronounced in Sweden. Sweden had a higher proportion of all AAA repairs because of rupture in the start of the study but by the end, the proportions were similar in both countries. Long-term survival improved for 65-79-old men in Sweden after start of screening.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: This study reveals improvements in results of AAA repair in Sweden. A decrease in rAAA repair and increase in iAAA repair were evident after AAA screening was started in 2006 and resulted in better outcomes. These changes are likely the result of AAA screening as they cannot be seen in neighbouring Finland that is lacking an AAA screening programme.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39374339/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241008141410&v=2.18.0.post9+e462414">39374339</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae665>10.1093/eurheartj/ehae665</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39374339</guid>
<pubDate>Mon, 07 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Matti T Laine</dc:creator>
<dc:creator>Kevin Mani</dc:creator>
<dc:creator>Kim Gunnarsson</dc:creator>
<dc:creator>Anders Wanhainen</dc:creator>
<dc:creator>Reijo Sund</dc:creator>
<dc:creator>Maarit Venermo</dc:creator>
<dc:date>2024-10-07</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Abdominal aortic aneurysm repair in Sweden vs. Finland: benefits of population-wide screening</dc:title>
<dc:identifier>pmid:39374339</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae665</dc:identifier>
</item>
<item>
<title>Can Exercise Injure the Sinus Node?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39374335/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241008141410&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Oct 8;150(15):1171-1173. doi: 10.1161/CIRCULATIONAHA.124.071607. Epub 2024 Oct 7.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39374335/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241008141410&v=2.18.0.post9+e462414">39374335</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.071607>10.1161/CIRCULATIONAHA.124.071607</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39374335</guid>
<pubDate>Mon, 07 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Paul D Thompson</dc:creator>
<dc:date>2024-10-07</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Can Exercise Injure the Sinus Node?</dc:title>
<dc:identifier>pmid:39374335</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.071607</dc:identifier>
</item>
<item>
<title>Challenges and Opportunities in Aortic Dissection: The Journey to Personalized Medicine</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39374333/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241008141410&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Oct 8;150(15):1155-1157. doi: 10.1161/CIRCULATIONAHA.124.071088. Epub 2024 Oct 7.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39374333/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241008141410&v=2.18.0.post9+e462414">39374333</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.071088>10.1161/CIRCULATIONAHA.124.071088</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39374333</guid>
<pubDate>Mon, 07 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Marion A Hofmann Bowman</dc:creator>
<dc:creator>Kim A Eagle</dc:creator>
<dc:date>2024-10-07</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Challenges and Opportunities in Aortic Dissection: The Journey to Personalized Medicine</dc:title>
<dc:identifier>pmid:39374333</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.071088</dc:identifier>
</item>
<item>
<title>Letter by Aldaas et al Regarding Article, "Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials"</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39374332/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241008141410&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Oct 8;150(15):e273. doi: 10.1161/CIRCULATIONAHA.123.068081. Epub 2024 Oct 7.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39374332/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241008141410&v=2.18.0.post9+e462414">39374332</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.068081>10.1161/CIRCULATIONAHA.123.068081</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39374332</guid>
<pubDate>Mon, 07 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Omar M Aldaas</dc:creator>
<dc:creator>Amer M Aldaas</dc:creator>
<dc:creator>Jonathan C Hsu</dc:creator>
<dc:date>2024-10-07</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Letter by Aldaas et al Regarding Article, "Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials"</dc:title>
<dc:identifier>pmid:39374332</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.068081</dc:identifier>
</item>
<item>
<title>Response by McIntyre et al to Letter Regarding Article, "Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials"</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39374331/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241008141410&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Oct 8;150(15):e274-e275. doi: 10.1161/CIRCULATIONAHA.124.071020. Epub 2024 Oct 7.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39374331/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241008141410&v=2.18.0.post9+e462414">39374331</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.071020>10.1161/CIRCULATIONAHA.124.071020</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39374331</guid>
<pubDate>Mon, 07 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>William F McIntyre</dc:creator>
<dc:creator>Alexander P Benz</dc:creator>
<dc:creator>Jeff S Healey</dc:creator>
<dc:creator>Renato Lopes</dc:creator>
<dc:date>2024-10-07</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Response by McIntyre et al to Letter Regarding Article, "Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials"</dc:title>
<dc:identifier>pmid:39374331</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.071020</dc:identifier>
</item>
<item>
<title>All That Is Gold Does Not Glitter</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39374330/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241008141410&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Oct 8;150(15):1158-1160. doi: 10.1161/CIRCULATIONAHA.124.069723. Epub 2024 Oct 7.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39374330/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241008141410&v=2.18.0.post9+e462414">39374330</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.069723>10.1161/CIRCULATIONAHA.124.069723</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39374330</guid>
<pubDate>Mon, 07 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Andrew M Luks</dc:creator>
<dc:creator>Benjamin D Levine</dc:creator>
<dc:date>2024-10-07</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>All That Is Gold Does Not Glitter</dc:title>
<dc:identifier>pmid:39374330</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.069723</dc:identifier>
</item>
<item>
<title>Mex3a Protects Against Atherosclerosis: Evidence From Mice and Humans</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39374329/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241008141410&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Oct 8;150(15):1213-1216. doi: 10.1161/CIRCULATIONAHA.124.069526. Epub 2024 Oct 7.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39374329/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241008141410&v=2.18.0.post9+e462414">39374329</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.069526>10.1161/CIRCULATIONAHA.124.069526</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39374329</guid>
<pubDate>Mon, 07 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Donato Santovito</dc:creator>
<dc:creator>James M Henderson</dc:creator>
<dc:creator>Kiril Bidzhekov</dc:creator>
<dc:creator>Vasiliki Triantafyllidou</dc:creator>
<dc:creator>Yvonne Jansen</dc:creator>
<dc:creator>Zhifen Chen</dc:creator>
<dc:creator>Floriana M Farina</dc:creator>
<dc:creator>Anastasiia Diagel</dc:creator>
<dc:creator>Maria Aslani</dc:creator>
<dc:creator>Xavier Blanchet</dc:creator>
<dc:creator>Heribert Schunkert</dc:creator>
<dc:creator>Remco T A Megens</dc:creator>
<dc:creator>Yvonne Döring</dc:creator>
<dc:creator>Michael Sattler</dc:creator>
<dc:creator>Christian Weber</dc:creator>
<dc:date>2024-10-07</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Mex3a Protects Against Atherosclerosis: Evidence From Mice and Humans</dc:title>
<dc:identifier>pmid:39374329</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.069526</dc:identifier>
</item>
<item>
<title>Our Collective Role in Cardiovascular Advocacy</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39373687/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241008141410&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2024 Sep 29:S0735-1097(24)08458-4. doi: 10.1016/j.jacc.2024.09.008. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39373687/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241008141410&v=2.18.0.post9+e462414">39373687</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.09.008>10.1016/j.jacc.2024.09.008</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39373687</guid>
<pubDate>Mon, 07 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Cathleen Biga</dc:creator>
<dc:date>2024-10-07</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Our Collective Role in Cardiovascular Advocacy</dc:title>
<dc:identifier>pmid:39373687</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.09.008</dc:identifier>
</item>
<item>
<title>Ablation Strategies for Repeat Procedures in Atrial Fibrillation Recurrences Despite Durable Pulmonary Vein Isolation: The Prospective Randomized ASTRO AF Multicenter Trial</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39371020/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241008141410&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: The current study did not detect superiority of cryoballoon-guided LAAI over low-voltage area ablation in patients with atrial fibrillation despite durable PVI.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Oct 7. doi: 10.1161/CIRCULATIONAHA.124.069993. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Ablation strategies for patients with symptomatic atrial fibrillation and isolated pulmonary veins vary and their effects on arrhythmia recurrence remain unclear. A prospective randomized German multicenter trial sought to compare 2 ablation strategies in this patient cohort.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Patients with atrial fibrillation despite durable pulmonary vein isolation were randomly assigned at 7 centers to undergo low-voltage area ablation using 3-dimensional mapping and irrigated radiofrequency current ablation (group A) or empirical left atrial appendage isolation (LAAI) using the cryoballoon followed by staged interventional left atrial appendage closure (group B). The primary end point was freedom from atrial tachyarrhythmias between 91 and 365 days after index ablation. The study was powered for superiority of LAAI compared with low-voltage area.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Patients (40% women; mean age, 68.8±8 years) with paroxysmal (32%) or persistent atrial fibrillation (68%) were randomized to undergo low-voltage area ablation (n=79) or cryoballoon-guided LAAI (n=82). After a planned interim analysis, enrollment was halted for futility on January 10, 2023. In the LAAI group, 77 of 82 left atrial appendages were successfully isolated with subsequent left atrial appendage closure in 57 patients. Procedure-related complications occurred in 4 (5%) and 11 (13.5%) patients in group A and B, respectively (<i>P</i>=0.10). The median follow-up was 367 days (interquartile range, 359-378). The Kaplan-Meier point estimate for freedom from atrial tachyarrhythmias was 51.7% (CI, 40.9%-65.4%) for group A and 55.5% (CI, 44.4%-69.2%; <i>P</i>=0.8069) for group B.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: The current study did not detect superiority of cryoballoon-guided LAAI over low-voltage area ablation in patients with atrial fibrillation despite durable PVI.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT04056390.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39371020/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241008141410&v=2.18.0.post9+e462414">39371020</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.069993>10.1161/CIRCULATIONAHA.124.069993</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39371020</guid>
<pubDate>Mon, 07 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Boris Schmidt</dc:creator>
<dc:creator>Stefano Bordignon</dc:creator>
<dc:creator>Andreas Metzner</dc:creator>
<dc:creator>Philipp Sommer</dc:creator>
<dc:creator>Daniel Steven</dc:creator>
<dc:creator>Tilmann Dahme</dc:creator>
<dc:creator>Matthias Busch</dc:creator>
<dc:creator>Roland Richard Tilz</dc:creator>
<dc:creator>David Schaack</dc:creator>
<dc:creator>Andreas Rillig</dc:creator>
<dc:creator>Christian Sohns</dc:creator>
<dc:creator>Arian Sultan</dc:creator>
<dc:creator>Karolina Weinmann-Emhardt</dc:creator>
<dc:creator>Astrid Hummel</dc:creator>
<dc:creator>Julia Vogler</dc:creator>
<dc:creator>Thomas Fink</dc:creator>
<dc:creator>Jakob Lueker</dc:creator>
<dc:creator>Alexander Pott</dc:creator>
<dc:creator>Christian Heeger</dc:creator>
<dc:creator>K-R Julian Chun</dc:creator>
<dc:date>2024-10-07</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Ablation Strategies for Repeat Procedures in Atrial Fibrillation Recurrences Despite Durable Pulmonary Vein Isolation: The Prospective Randomized ASTRO AF Multicenter Trial</dc:title>
<dc:identifier>pmid:39371020</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.069993</dc:identifier>
</item>
<item>
<title>Identifying specific functional roles for senescence across cell types</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39368477/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241008141410&amp;v=2.18.0.post9+e462414
      <description>Cellular senescence plays critical roles in aging, regeneration, and disease; yet, the ability to discern its contributions across various cell types to these biological processes remains limited. In this study, we generated an in vivo genetic toolbox consisting of three p16^(Ink4a)-related intersectional genetic systems, enabling pulse-chase tracing (Sn-pTracer), Cre-based tracing and ablation (Sn-cTracer), and gene manipulation combined with tracing (Sn-gTracer) of defined p16^(Ink4a+) cell...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Oct 1:S0092-8674(24)01069-9. doi: 10.1016/j.cell.2024.09.021. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Cellular senescence plays critical roles in aging, regeneration, and disease; yet, the ability to discern its contributions across various cell types to these biological processes remains limited. In this study, we generated an in vivo genetic toolbox consisting of three p16<sup>Ink4a</sup>-related intersectional genetic systems, enabling pulse-chase tracing (Sn-pTracer), Cre-based tracing and ablation (Sn-cTracer), and gene manipulation combined with tracing (Sn-gTracer) of defined p16<sup>Ink4a+</sup> cell types. Using liver injury and repair as an example, we found that macrophages and endothelial cells (ECs) represent distinct senescent cell populations with different fates and functions during liver fibrosis and repair. Notably, clearance of p16<sup>Ink4a+</sup> macrophages significantly mitigates hepatocellular damage, whereas eliminating p16<sup>Ink4a+</sup> ECs aggravates liver injury. Additionally, targeted reprogramming of p16<sup>Ink4a+</sup> ECs through Kdr overexpression markedly reduces liver fibrosis. This study illuminates the functional diversity of p16<sup>Ink4a+</sup> cells and offers insights for developing cell-type-specific senolytic therapies in the future.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39368477/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241008141410&v=2.18.0.post9+e462414">39368477</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.09.021>10.1016/j.cell.2024.09.021</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39368477</guid>
<pubDate>Sat, 05 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Huan Zhao</dc:creator>
<dc:creator>Zixin Liu</dc:creator>
<dc:creator>Hui Chen</dc:creator>
<dc:creator>Maoying Han</dc:creator>
<dc:creator>Mingjun Zhang</dc:creator>
<dc:creator>Kuo Liu</dc:creator>
<dc:creator>Hengwei Jin</dc:creator>
<dc:creator>Xiuxiu Liu</dc:creator>
<dc:creator>Mengyang Shi</dc:creator>
<dc:creator>Wenjuan Pu</dc:creator>
<dc:creator>Markus Werner</dc:creator>
<dc:creator>Michael Meister</dc:creator>
<dc:creator>Stefan G Kauschke</dc:creator>
<dc:creator>Ruilin Sun</dc:creator>
<dc:creator>Jinjin Wang</dc:creator>
<dc:creator>Ruling Shen</dc:creator>
<dc:creator>Qing-Dong Wang</dc:creator>
<dc:creator>Xin Ma</dc:creator>
<dc:creator>Jan S Tchorz</dc:creator>
<dc:creator>Bin Zhou</dc:creator>
<dc:date>2024-10-05</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Identifying specific functional roles for senescence across cell types</dc:title>
<dc:identifier>pmid:39368477</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.09.021</dc:identifier>
</item>
<item>
<title>A protein blueprint of the diatom CO&lt;sub>;2&lt;/sub>;-fixing organelle</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39368476/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241008141410&amp;v=2.18.0.post9+e462414
      <description>Diatoms are central to the global carbon cycle. At the heart of diatom carbon fixation is an overlooked organelle called the pyrenoid, where concentrated CO(2) is delivered to densely packed Rubisco. Diatom pyrenoids fix approximately one-fifth of global CO(2), but the protein composition of this organelle is largely unknown. Using fluorescence protein tagging and affinity purification-mass spectrometry, we generate a high-confidence spatially defined protein-protein interaction network for the...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Oct 3:S0092-8674(24)01073-0. doi: 10.1016/j.cell.2024.09.025. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Diatoms are central to the global carbon cycle. At the heart of diatom carbon fixation is an overlooked organelle called the pyrenoid, where concentrated CO<sub>2</sub> is delivered to densely packed Rubisco. Diatom pyrenoids fix approximately one-fifth of global CO<sub>2</sub>, but the protein composition of this organelle is largely unknown. Using fluorescence protein tagging and affinity purification-mass spectrometry, we generate a high-confidence spatially defined protein-protein interaction network for the diatom pyrenoid. Within our pyrenoid interaction network are 10 proteins with previously unknown functions. We show that six of these form a shell that encapsulates the Rubisco matrix and is critical for pyrenoid structural integrity, shape, and function. Although not conserved at a sequence or structural level, the diatom pyrenoid shares some architectural similarities to prokaryotic carboxysomes. Collectively, our results support the convergent evolution of pyrenoids across the two main plastid lineages and uncover a major structural and functional component of global CO<sub>2</sub> fixation.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39368476/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241008141410&v=2.18.0.post9+e462414">39368476</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.09.025>10.1016/j.cell.2024.09.025</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39368476</guid>
<pubDate>Sat, 05 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Onyou Nam</dc:creator>
<dc:creator>Sabina Musiał</dc:creator>
<dc:creator>Manon Demulder</dc:creator>
<dc:creator>Caroline McKenzie</dc:creator>
<dc:creator>Adam Dowle</dc:creator>
<dc:creator>Matthew Dowson</dc:creator>
<dc:creator>James Barrett</dc:creator>
<dc:creator>James N Blaza</dc:creator>
<dc:creator>Benjamin D Engel</dc:creator>
<dc:creator>Luke C M Mackinder</dc:creator>
<dc:date>2024-10-05</dc:date>
<dc:source>Cell</dc:source>
<dc:title>A protein blueprint of the diatom CO&lt;sub>;2&lt;/sub>;-fixing organelle</dc:title>
<dc:identifier>pmid:39368476</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.09.025</dc:identifier>
</item>
<item>
<title>A genome-wide spectrum of tandem repeat expansions in 338,963 humans</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39368475/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241008141410&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Oct 4:S0092-8674(24)01145-0. doi: 10.1016/j.cell.2024.09.045. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39368475/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241008141410&v=2.18.0.post9+e462414">39368475</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.09.045>10.1016/j.cell.2024.09.045</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39368475</guid>
<pubDate>Sat, 05 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Ya Cui</dc:creator>
<dc:creator>Wenbin Ye</dc:creator>
<dc:creator>Jason Sheng Li</dc:creator>
<dc:creator>Jingyi Jessica Li</dc:creator>
<dc:creator>Eric Vilain</dc:creator>
<dc:creator>Tamer Sallam</dc:creator>
<dc:creator>Wei Li</dc:creator>
<dc:date>2024-10-05</dc:date>
<dc:source>Cell</dc:source>
<dc:title>A genome-wide spectrum of tandem repeat expansions in 338,963 humans</dc:title>
<dc:identifier>pmid:39368475</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.09.045</dc:identifier>
</item>
<item>
<title>New light shed on the treatment of heart failure and on novel therapeutic targets</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39367734/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241008141410&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Oct 5;45(37):3775-3779. doi: 10.1093/eurheartj/ehae643.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39367734/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241008141410&v=2.18.0.post9+e462414">39367734</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae643>10.1093/eurheartj/ehae643</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39367734</guid>
<pubDate>Sat, 05 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Filippo Crea</dc:creator>
<dc:date>2024-10-05</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>New light shed on the treatment of heart failure and on novel therapeutic targets</dc:title>
<dc:identifier>pmid:39367734</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae643</dc:identifier>
</item>
<item>
<title>Rift Valley fever virus coordinates the assembly of a programmable E3 ligase to promote viral replication</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39366381/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241008141410&amp;v=2.18.0.post9+e462414
      <description>Viruses encode strategies to degrade cellular proteins to promote infection and pathogenesis. Here, we revealed that the non-structural protein NSs of Rift Valley fever virus forms a filamentous E3 ligase to trigger efficient degradation of targeted proteins. Reconstitution in vitro and cryoelectron microscopy analysis with the 2.9-Å resolution revealed that NSs forms right-handed helical fibrils. The NSs filamentous oligomers associate with the cellular FBXO3 to form a remodeled E3 ligase. The...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Sep 26:S0092-8674(24)01026-2. doi: 10.1016/j.cell.2024.09.008. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Viruses encode strategies to degrade cellular proteins to promote infection and pathogenesis. Here, we revealed that the non-structural protein NSs of Rift Valley fever virus forms a filamentous E3 ligase to trigger efficient degradation of targeted proteins. Reconstitution in vitro and cryoelectron microscopy analysis with the 2.9-Å resolution revealed that NSs forms right-handed helical fibrils. The NSs filamentous oligomers associate with the cellular FBXO3 to form a remodeled E3 ligase. The NSs-FBXO3 E3 ligase targets the cellular TFIIH complex through the NSs-P62 interaction, leading to ubiquitination and proteasome-dependent degradation of the TFIIH complex. NSs-FBXO3-triggered TFIIH complex degradation resulted in robust inhibition of antiviral immunity and promoted viral pathogenesis in vivo. Furthermore, it is demonstrated that NSs can be programmed to target additional proteins for proteasome-dependent degradation, serving as a versatile targeted protein degrader. These results showed that a virulence factor forms a filamentous and programmable degradation machinery to induce organized degradation of cellular proteins to promote viral infection.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39366381/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241008141410&v=2.18.0.post9+e462414">39366381</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.09.008>10.1016/j.cell.2024.09.008</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39366381</guid>
<pubDate>Fri, 04 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Huiling Li</dc:creator>
<dc:creator>Yulan Zhang</dc:creator>
<dc:creator>Guibo Rao</dc:creator>
<dc:creator>Chongtao Zhang</dc:creator>
<dc:creator>Zhenqiong Guan</dc:creator>
<dc:creator>Ziyan Huang</dc:creator>
<dc:creator>Shufen Li</dc:creator>
<dc:creator>Pierre-Yves Lozach</dc:creator>
<dc:creator>Sheng Cao</dc:creator>
<dc:creator>Ke Peng</dc:creator>
<dc:date>2024-10-04</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Rift Valley fever virus coordinates the assembly of a programmable E3 ligase to promote viral replication</dc:title>
<dc:identifier>pmid:39366381</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.09.008</dc:identifier>
</item>
<item>
<title>Cryo-EM vs. Disease X</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39366340/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241008141410&amp;v=2.18.0.post9+e462414
      <description>In this issue of Cell, Penzes et al. describe the use of cryo-EM to identify the cause of a mysterious disease affecting farmed superworms across the US. The study illustrates the power of ex vivo cryo-EM, which uses amplification-free samples to advance at once diagnostic, DNA packaging mechanism, and preventative measures.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Oct 3;187(20):5497-5499. doi: 10.1016/j.cell.2024.09.002.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">In this issue of Cell, Penzes et al. describe the use of cryo-EM to identify the cause of a mysterious disease affecting farmed superworms across the US. The study illustrates the power of ex vivo cryo-EM, which uses amplification-free samples to advance at once diagnostic, DNA packaging mechanism, and preventative measures.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39366340/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241008141410&v=2.18.0.post9+e462414">39366340</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.09.002>10.1016/j.cell.2024.09.002</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39366340</guid>
<pubDate>Fri, 04 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Fasséli Coulibaly</dc:creator>
<dc:date>2024-10-04</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Cryo-EM vs. Disease X</dc:title>
<dc:identifier>pmid:39366340</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.09.002</dc:identifier>
</item>
<item>
<title>A call from patient-researchers to advance research on long COVID</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39366339/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241008141410&amp;v=2.18.0.post9+e462414
      <description>Long COVID is a chronic and often disabling illness with long-term consequences. Although progress has been made in the clinical characterization of long COVID, no approved treatments exist and disconnects between patients and researchers threaten to hinder future progress. Incorporating patients as active collaborators in long COVID research can bridge the gap and accelerate progress toward treatments and cures.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Oct 3;187(20):5490-5496. doi: 10.1016/j.cell.2024.09.011.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Long COVID is a chronic and often disabling illness with long-term consequences. Although progress has been made in the clinical characterization of long COVID, no approved treatments exist and disconnects between patients and researchers threaten to hinder future progress. Incorporating patients as active collaborators in long COVID research can bridge the gap and accelerate progress toward treatments and cures.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39366339/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241008141410&v=2.18.0.post9+e462414">39366339</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.09.011>10.1016/j.cell.2024.09.011</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39366339</guid>
<pubDate>Fri, 04 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Megan L Fitzgerald</dc:creator>
<dc:creator>Alison K Cohen</dc:creator>
<dc:creator>Toni Wall Jaudon</dc:creator>
<dc:creator>Julia Moore Vogel</dc:creator>
<dc:creator>Abigail N Koppes</dc:creator>
<dc:creator>Lucia Santos</dc:creator>
<dc:creator>Rachel Robles</dc:creator>
<dc:creator>Jerry Lin</dc:creator>
<dc:creator>J D Davids</dc:creator>
<dc:creator>Chris McWilliams</dc:creator>
<dc:creator>Signe Redfield</dc:creator>
<dc:creator>Kathleen P Banks</dc:creator>
<dc:creator>Maria Richardson</dc:creator>
<dc:creator>Teresa T Tindle Akintonwa</dc:creator>
<dc:creator>Beth Pollack</dc:creator>
<dc:creator>Ezra Spier</dc:creator>
<dc:creator>Aimee Weiss</dc:creator>
<dc:creator>Gina Assaf</dc:creator>
<dc:creator>Hannah Davis</dc:creator>
<dc:creator>Lisa McCorkell</dc:creator>
<dc:date>2024-10-04</dc:date>
<dc:source>Cell</dc:source>
<dc:title>A call from patient-researchers to advance research on long COVID</dc:title>
<dc:identifier>pmid:39366339</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.09.011</dc:identifier>
</item>





























</channel>
</rss>